Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$5,997,150
+$1,398,300 QoQ
Shares Held
5,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
5.18%
of 13F equity value
Holder Rank
#1,579
of 4,621 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sivik Global Healthcare LLC holds $30,182,950 across 7 Drug Manufacturers - General names. LLY ranks #1 (19.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,000 | $5,997,150 | |
| 2 | MRK |
Merck & Co., Inc.
|
40,000 | $5,140,000 | |
| 3 | JNJ |
Johnson & Johnson
|
20,000 | $5,079,400 | |
| 4 | AZN |
Astrazeneca PLC
|
20,000 | $3,792,400 | |
| 5 | ABBV |
AbbVie Inc.
|
15,000 | $3,774,600 | |
| 6 | BIIB |
Biogen Inc.
|
15,000 | $3,240,900 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
25,000 | $3,158,500 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,997,150 | 5,000 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $4,598,850 | 5,000 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $7,522,760 | 7,000 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $7,630,000 | 10,000 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $8,574,830 | 11,000 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $7,433,190 | 9,000 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $11,580,000 | 15,000 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $12,846,130 | 14,500 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $13,580,700 | 15,000 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $12,447,360 | 16,000 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $8,743,800 | 15,000 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $8,056,950 | 15,000 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $8,207,150 | 17,500 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $6,868,400 | 20,000 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $6,402,200 | 17,500 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $5,658,625 | 17,500 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $6,971,593 | 21,502 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,863,700 | 10,000 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $7,596,050 | 27,500 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $8,086,750 | 35,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,180,800 | 40,000 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $5,909,400 | 35,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,141,100 | 55,000 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $8,323,200 | 60,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||